[ 英語タイトル ] Microbial Identification Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083128

Survey : Mordor Intelligence

Publish On : November, 2020

Number of Pages : 114

Category : Healthcare and Pharmaceuticals

Report format : PDF

Sales price option (consumption tax not included)

[Report Description]

Several technological advancements that use simple molecular methods have been available in the market, for the past few years. These technologies aid in microbial identification and have the potential for providing cost-benefits, specifically for peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) and targeted real-time PCR, such as GeneXpert assays. PNA-FISH has been the most extensively studied technology, in terms of the collaboration between pharmacy and medical intervention. Multiplex and broad-range molecular diagnostics are capable of reducing the result-time and increased sensitivity, as compared to growth-based blood culture systems.

Furthermore, thousands of pathogens are known to cause diseases in humans, and standard PCR assays have been developed to detect the most commonly occurring pathogens. Pyrosequencing and multitarget PCRs are two essential strategies, which are currently under development, primarily for clinical laboratories. Additionally, these new broad-based techniques are gaining immense popularity, due to their ability to identify organisms that are difficult to culture, including newly emerging strains. Moreover, their capacity to track disease transmission is expected to drive their adoption.

Therefore, the microbial identification market is expected to witness growth over the forecast period, due to advancements in microbial identification. The technologies that are expected to lower costs and result time, while providing greater efficiency are expected to witness high adoption rates.

Key Market Trends

Instruments are Driving the Product and Service Segment's Growth

There have been major advancements in the identification techniques of clinically significant microorganisms. The spectrum of the identifiable organism has steadily increased over the years, to become more inclusive of various microorganism strains. These include methods of faster identification of isolated organisms, with mass spectrometry (MS) in clinical specimens. According to the World Health Organization, at least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. With the increasing prevalence of infectious diseases, there is an increasing need to identify the microorganism causing them, and hence the segment growth.

Instruments for microbial identification are based on techniques of mass spectrometry (MS), polymerase chain reaction (PCR), and time-of-flight mass spectrometry (TOF-MS). However, these advanced microbial identification systems are not available uniformly across the world. Such factors are expected to provide various growth opportunities for the market studied over the forecast period.

The North American Region Accounts for the Largest Share in the Market

Due to various technological advancements in the North American region, it has a good hold on the latest technologies available in the market. Moreover, the presence of major players indicates high availability of products that are related to microbial identification. However, some products of microbial identification are yet to be approved in the United States. This is hindering the growth of the market studied in the region.

Competitive Landscape

The market studied is moderately competitive, with presence of both global and local players. In terms of major players, few companies are currently accounting for a healthy market share. For instance, Thermofisher Scientific, BioMérieux SA, Beckman Coulter Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market, along with local and smaller companies that hold a substantial share.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support